论文部分内容阅读
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is a therapy used in regenerative medicine for the recovery of bone marrow function in patients with hematologic diseases.This therapy requieres HLA matched donors and its success greatly depends on an early graft.Furthermore,its critical the avoidance of graft versus host disease (GVHD) onset.